These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36610790)

  • 21. Safety, long-term outcomes and predictors of recurrence after first-line combined endoepicardial ventricular tachycardia substrate ablation in arrhythmogenic cardiomyopathy. Impact of arrhythmic substrate distribution pattern. A prospective multicentre study.
    Berruezo A; Acosta J; Fernández-Armenta J; Pedrote A; Barrera A; Arana-Rueda E; Bodegas AI; Anguera I; Tercedor L; Penela D; Andreu D; Perea RJ; Prat-González S; Mont L
    Europace; 2017 Apr; 19(4):607-616. PubMed ID: 28431051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arrhythmogenic right ventricular cardiomyopathy. Antiarrhythmic drugs, catheter ablation, or ICD?
    Wichter T; Paul TM; Eckardt L; Gerdes P; Kirchhof P; Böcker D; Breithardt G
    Herz; 2005 Mar; 30(2):91-101. PubMed ID: 15875097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ventricular arrhythmias and sudden cardiac death.
    John RM; Tedrow UB; Koplan BA; Albert CM; Epstein LM; Sweeney MO; Miller AL; Michaud GF; Stevenson WG
    Lancet; 2012 Oct; 380(9852):1520-9. PubMed ID: 23101719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium.
    Nademanee K; Veerakul G; Chandanamattha P; Chaothawee L; Ariyachaipanich A; Jirasirirojanakorn K; Likittanasombat K; Bhuripanyo K; Ngarmukos T
    Circulation; 2011 Mar; 123(12):1270-9. PubMed ID: 21403098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epicardial substrate and outcome with epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy/dysplasia.
    Garcia FC; Bazan V; Zado ES; Ren JF; Marchlinski FE
    Circulation; 2009 Aug; 120(5):366-75. PubMed ID: 19620503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elimination of fatal arrhythmias through ablation of triggering premature ventricular contraction in type 3 long QT syndrome.
    Cheng Z; Gao P; Cheng K; Chen T; Deng H; Chang B; Fang Q
    Ann Noninvasive Electrocardiol; 2012 Oct; 17(4):394-7. PubMed ID: 23094886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term follow-up of arrhythmogenic right ventricular cardiomyopathy patients with an implantable cardioverter-defibrillator for prevention of sudden cardiac death.
    Yin K; Ding L; Li Y; Hua W
    Clin Cardiol; 2017 Apr; 40(4):216-221. PubMed ID: 28139837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Catheter ablation to prevent sudden cardiac death.
    Kautzner J; Peichl P
    Int J Cardiol; 2017 Jun; 237():29-33. PubMed ID: 28433554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the arrhythmogenic substrate in ischemic and nonischemic cardiomyopathy implications for catheter ablation of hemodynamically unstable ventricular tachycardia.
    Nakahara S; Tung R; Ramirez RJ; Michowitz Y; Vaseghi M; Buch E; Gima J; Wiener I; Mahajan A; Boyle NG; Shivkumar K
    J Am Coll Cardiol; 2010 May; 55(21):2355-65. PubMed ID: 20488307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-invasive assessment of the arrhythmogenic substrate in Brugada syndrome using signal-averaged electrocardiogram: clinical implications from a prospective clinical trial.
    Ciconte G; Santinelli V; Vicedomini G; Borrelli V; Monasky MM; Micaglio E; Giannelli L; Negro G; Giordano F; Mecarocci V; Mazza BC; Locati E; Anastasia L; Calovic Z; Pappone C
    Europace; 2019 Dec; 21(12):1900-1910. PubMed ID: 31647530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implantable Cardioverter-Defibrillator Therapy in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Predictors of Appropriate Therapy, Outcomes, and Complications.
    Orgeron GM; James CA; Te Riele A; Tichnell C; Murray B; Bhonsale A; Kamel IR; Zimmerman SL; Judge DP; Crosson J; Tandri H; Calkins H
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28588093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Arrhythmogenic cardiomyopathy of the right ventricle. Predictive value of QT interval dispersion to assess arrhythmogenic risk and sudden death.
    Fagundes ML; Maia IG; Cruz FE; Alves PA; Boghossian SH; Ribeiro JC; Sá R
    Arq Bras Cardiol; 2000 Aug; 75(2):115-24. PubMed ID: 10983028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Three-dimensional electroanatomical voltage mapping and histologic evaluation of myocardial substrate in right ventricular outflow tract tachycardia.
    Corrado D; Basso C; Leoni L; Tokajuk B; Turrini P; Bauce B; Migliore F; Pavei A; Tarantini G; Napodano M; Ramondo A; Buja G; Iliceto S; Thiene G
    J Am Coll Cardiol; 2008 Feb; 51(7):731-9. PubMed ID: 18279737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular biology and cellular mechanisms of Brugada and long QT syndromes in infants and young children.
    Antzelevitch C
    J Electrocardiol; 2001; 34 Suppl():177-81. PubMed ID: 11781953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel method to enhance phenotype, epicardial functional substrates, and ventricular tachyarrhythmias in Brugada syndrome.
    Chung FP; Raharjo SB; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chao TF; Liao JN; Lin CY; Chang YT; Hung Y; Te A; Yamada S; Tasaka H; Wang CT; Chen SA
    Heart Rhythm; 2017 Apr; 14(4):508-517. PubMed ID: 28065832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Larger low voltage zone in endocardial unipolar map compared with that in epicardial bipolar map indicates difficulty in eliminating ventricular tachycardia by catheter ablation.
    Miyamoto K; Noda T; Satomi K; Wada M; Nakajima I; Ishibashi K; Okamura H; Noguchi T; Anzai T; Yasuda S; Ogawa H; Shimizu W; Aiba T; Kamakura S; Kusano K
    Heart Vessels; 2016 Aug; 31(8):1337-46. PubMed ID: 26266635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endo/epicardial ablation of ventricular arrhythmias with contact force-sensing catheters in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Aras D; Özcan F; Çay S; Özeke Ö; Kara M; Topaloğlu S
    Anatol J Cardiol; 2019 Mar; 21(4):187-195. PubMed ID: 30930451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-Term Clinical Outcome of Arrhythmogenic Right Ventricular Cardiomyopathy in Individuals With a p.S358L Mutation in TMEM43 Following Implantable Cardioverter Defibrillator Therapy.
    Hodgkinson KA; Howes AJ; Boland P; Shen XS; Stuckless S; Young TL; Curtis F; Collier A; Parfrey PS; Connors SP
    Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):. PubMed ID: 26966288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utility of ripple mapping for identification of slow conduction channels during ventricular tachycardia ablation in the setting of arrhythmogenic right ventricular cardiomyopathy.
    Xie S; Kubala M; Liang JJ; Yang J; Desjardins B; Santangeli P; van der Geest RJ; Schaller R; Riley M; Supple G; Frankel DS; Callans D; Pac EZ; Marchlinski F; Nazarian S
    J Cardiovasc Electrophysiol; 2019 Mar; 30(3):366-373. PubMed ID: 30575168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Left cardiac sympathetic denervation for the management of life-threatening ventricular tachyarrhythmias in young patients with catecholaminergic polymorphic ventricular tachycardia and long QT syndrome.
    Schneider HE; Steinmetz M; Krause U; Kriebel T; Ruschewski W; Paul T
    Clin Res Cardiol; 2013 Jan; 102(1):33-42. PubMed ID: 22821214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.